Complex regional pain syndrome: A loss of inhibition?

Pain

Volumn 142, Issue 3, 2009, Pages 177-178

  Birklein, F ^a   Kingery, W S ^b,c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; CALCIUM CHANNEL BLOCKING AGENT; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; NEUROPEPTIDE;

CELLULAR IMMUNITY; CHRONIC PAIN; CLINICAL FEATURE; COMPLEX REGIONAL PAIN SYNDROME; CYTOKINE RELEASE; EDITORIAL; HEADACHE; HUMAN; HYPERTENSION; MIGRAINE; NEUROGENIC INFLAMMATION; NOCICEPTION; NONHUMAN; POSTTRAUMATIC PAIN; PRIORITY JOURNAL;

COMPLEX REGIONAL PAIN SYNDROMES; HUMANS; INFLAMMATION; MODELS, IMMUNOLOGICAL; NEURAL INHIBITION;

EID: 61749096682     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2009.01.029     Document Type: Editorial

References (22)

1. Birklein F. Chapter 35 complex regional pain syndrome. Handb Clin Neurol 81 (2006) 529-546
2. Birklein F., and Schmelz M. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett 437 (2008) 199-202
3. Birklein F., Schmelz M., Schifter S., and Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology 57 (2001) 2179-2184
4. Blair S.J., Chinthagada M., Hoppenstehdt D., Kijowski R., and Fareed J. Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. Acta Orthop Belg 64 (1998) 448-451
5. de Mos M., Huygen F.J., Dieleman J.P., Koopman J.S., Stricker B.H., and Sturkenboom M.C. Medical history and the onset of complex regional pain syndrome (CRPS). Pain 139 (2008) 458-466
6. de Mos M., Huygen F.J.P.M., Stricker B.H.Ch., Dieleman J.P., and Sturkenboom M.C.J.M. The association between ACE inhibitors and the complex regional pain syndrome: Suggestions for a neuro-inflammatory pathogenesis of CRPS. Pain 142 (2009) 218-224
7. Dijkstra P.U., Groothoff J.W., ten Duis H.J., and Geertzen J.H. Incidence of complex regional pain syndrome type I after fractures of the distal radius. Eur J Pain 7 (2003) 457-462
8. Groeneweg J.G., Huygen F.J., Heijmans-Antonissen C., Niehof S., and Zijlstra F.J. Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1. BMC Musculoskelet Disord 7 (2006) 91
9. Guo T.Z., Offley S.C., Boyd E.A., Jacobs C.R., and Kingery W.S. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. Pain 108 (2004) 95-107
10. Guo T.Z., Wei T., and Kingery W.S. Glucocorticoid inhibition of vascular abnormalities in a tibia fracture rat model of complex regional pain syndrome type I. Pain 121 (2006) 158-167
11. Ho T.W., Ferrari M.D., Dodick D.W., Galet V., Kost J., Fan X., Leibensperger H., Froman S., Assaid C., Lines C., Koppen H., and Winner P.K. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet (2008)
12. Kozin F., McCarty D.J., Sims J., and Genant H. The reflex sympathetic dystrophy syndrome. I. Clinical and histologic studies: evidence for bilaterality, response to corticosteroids and articular involvement. Am J Med 60 (1976) 321-331
13. Kramer H.H., He L., Lu B., Birklein F., and Sommer C. Increased pain and neurogenic inflammation in mice deficient of neutral endopeptidase. Neurobiol Dis (2008) [Epub ahead of print]
14. Kramer H.H., Schmidt K., Leis S., Schmelz M., Sommer C., and Birklein F. Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation. Exp Neurol 195 (2005) 179-184
15. Leis S., Weber M., Isselmann A., Schmelz M., and Birklein F. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol 183 (2003) 197-204
16. Opree A., and Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci 20 (2000) 6289-6293
17. Sabsovich I., Guo T.Z., Wei T., Zhao R., Li X., Clark D.J., Geis C., Sommer C., and Kingery W.S. TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain 137 (2008) 507-519
18. Sabsovich I., Wei T., Guo T.Z., Zhao R., Shi X., Li X., Yeomans D.C., Klyukinov M., Kingery W.S., and Clark J.D. Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain 138 (2008) 47-60
19. Weber M., Birklein F., Neundorfer B., and Schmelz M. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain 91 (2001) 251-257
20. Wei T., Sabsovich I., Guo T.Z., Shi X., Zhao R., Li W., Geis C., Sommer C., Kingery W.S., and Clark D.J. Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome. Eur J Pain 13 (2009) 253-262
21. Wesseldijk F., Huygen F.J., Heijmans-Antonissen C., Niehof S.P., and Zijlstra F.J. Tumor necrosis factor-alpha and interleukin-6 are not correlated with the characteristics of complex regional pain syndrome type 1 in 66 patients. Eur J Pain 12 (2008) 716-721
22. Zollinger P.E., Tuinebreijer W.E., Kreis R.W., and Breederveld R.S. Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomised trial. Lancet 354 (1999) 2025-2028